SCYNEXIS INC 8-K

What Happened

• SCYNEXIS, Inc. (SCYX) announced in an 8-K filed April 20, 2026 that Board member Steven C. Gilman notified the company on April 16, 2026 that he intends to retire and will not stand for reelection at the company's 2026 annual meeting of stockholders. His current term will end at the conclusion of that meeting. The filing states his resignation is not due to any disagreement with the company.

Key Details

• Notice given: April 16, 2026; Form 8-K filed: April 20, 2026.
• Dr. Gilman will remain Chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee until the 2026 Annual Meeting.
• The filing explicitly states his departure was not due to any disagreement with the company on operations, policies, practices or strategy.
• The 8-K was signed by CEO David Angulo, M.D.

Why It Matters

• Director departures affect board composition and committee membership; investors should note Dr. Gilman’s role as Compensation Committee Chair until the annual meeting. The filing does not identify a successor or provide additional governance changes, so shareholders may watch subsequent filings or proxy materials for the company’s plan to fill the board seat and any committee reassignments.